Gainer JV - Search Results

1

Frequency of functionally important beta-2 adrenoceptor polymorphisms varies markedly among African-American, Caucasian and Chinese individuals.

Xie HG, Stein CM, Kim RB, Xiao ZS, He N, Zhou HH, Gainer JV, Brown NJ, Haines JL, Wood AJ. Xie HG, et al. Among authors: gainer jv. Pharmacogenetics. 1999 Aug;9(4):511-6. Pharmacogenetics. 1999. PMID: 10780271

2

Alpha1A-adrenergic receptor polymorphism: association with ethnicity but not essential hypertension.

Xie HG, Kim RB, Stein CM, Gainer JV, Brown NJ, Wood AJ. Xie HG, et al. Among authors: gainer jv. Pharmacogenetics. 1999 Oct;9(5):651-6. Pharmacogenetics. 1999. PMID: 10591546

3

Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans.

Xie HG, Stein CM, Kim RB, Gainer JV, Sofowora G, Dishy V, Brown NJ, Goree RE, Haines JL, Wood AJ. Xie HG, et al. Among authors: gainer jv. Clin Pharmacol Ther. 2000 Jun;67(6):670-5. doi: 10.1067/mcp.2000.106293. Clin Pharmacol Ther. 2000. PMID: 10872649

4

Angiotensin II type I receptor polymorphism in African Americans lower frequency of the C1166 variant.

Gainer JV, Hunley TE, Kon V, Nadeau JH, Muldowney JA 3rd, Brown NJ. Gainer JV, et al. Biochem Mol Biol Int. 1997 Sep;43(1):227-31. doi: 10.1080/15216549700204001. Biochem Mol Biol Int. 1997. PMID: 9315301

5

Altered frequency of a promoter polymorphism of the kinin B2 receptor gene in hypertensive African-Americans.

Gainer JV, Brown NJ, Bachvarova M, Bastien L, Maltais I, Marceau F, Bachvarov DR. Gainer JV, et al. Am J Hypertens. 2000 Dec;13(12):1268-73. doi: 10.1016/s0895-7061(00)01215-2. Am J Hypertens. 2000. PMID: 11130770

6

Increased sensitivity to bradykinin among African Americans.

Gainer JV, Nadeau JH, Ryder D, Brown NJ. Gainer JV, et al. J Allergy Clin Immunol. 1996 Aug;98(2):283-7. doi: 10.1016/s0091-6749(96)70151-3. J Allergy Clin Immunol. 1996. PMID: 8757204 Clinical Trial.

7

Bradykinin stimulates tissue plasminogen activator release in human vasculature.

Brown NJ, Gainer JV, Stein CM, Vaughan DE. Brown NJ, et al. Among authors: gainer jv. Hypertension. 1999 Jun;33(6):1431-5. doi: 10.1161/01.hyp.33.6.1431. Hypertension. 1999. PMID: 10373228

8

Angiotensin-converting enzyme insertion/deletion polymorphism modulates the human in vivo metabolism of bradykinin.

Murphey LJ, Gainer JV, Vaughan DE, Brown NJ. Murphey LJ, et al. Among authors: gainer jv. Circulation. 2000 Aug 22;102(8):829-32. doi: 10.1161/01.cir.102.8.829. Circulation. 2000. PMID: 10952948

9

The bradykinin type 2 receptor BE1 polymorphism and ethnicity influence systolic blood pressure and vascular resistance.

Pretorius MM, Gainer JV, Van Guilder GP, Coelho EB, Luther JM, Fong P, Rosenbaum DD, Malave HA, Yu C, Ritchie MD, Vaughan DE, Brown NJ. Pretorius MM, et al. Among authors: gainer jv. Clin Pharmacol Ther. 2008 Jan;83(1):122-9. doi: 10.1038/sj.clpt.6100250. Epub 2007 May 23. Clin Pharmacol Ther. 2008. PMID: 17522594 Clinical Trial.

10

Bradykinin stimulates tissue plasminogen activator release from human forearm vasculature through B(2) receptor-dependent, NO synthase-independent, and cyclooxygenase-independent pathway.

Brown NJ, Gainer JV, Murphey LJ, Vaughan DE. Brown NJ, et al. Among authors: gainer jv. Circulation. 2000 Oct 31;102(18):2190-6. doi: 10.1161/01.cir.102.18.2190. Circulation. 2000. PMID: 11056091 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

42 results

Search Page

Filters